References
- Millar J, Johnston A, Lamb B. Allergic aspergillosis of the maxillary sinuses (abstract). Thorax 1981; 36: 710
- Katzenstein A, Sale S, Greenberger P. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983; 72: 89–93
- Feger T, Rupp N, Kuhn F, et al. Local and systemic eosinophil activation in allergic fungal sinusitis. Ann Allergy Asthma Immunol 1997; 79: 221–225
- Chrzanowski RR, Rupp NT, Kuhn FA, et al. Allergenic fungi in allergic fungal sinusitis. Ann Allergy Asthma Immunol 1997; 79: 431–435
- McCann WA, Cromie M, Chandler F, Ford J, Dolen WK. Sensitization to recombinant Aspergillus fumigatus allergens in allergic fungal sinusitis. Ann Allergy Asthma Immunol 2002; 89: 203–208
- Hemmann S, Menz G, Isamil C, et al. Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A. fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization. J Allergy Clin Immunol 1999; 104: 601–607
- Schubert MS. A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol 2001; 87: 181–188
- Chauhan B, Santiago L, Hutcheson PS, et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000; 106: 723–729
- Schubert MS, Hutcheson PS, Graff RJ, Santiago L, Slavin RG. HLA-DQB1*03 in allergic fungal sinusitis and other chronic hypertrophic rhinosinusitis disorders. J Allergy Clin Immunol 2004; 114: 1376–1383